Skip to main content

Table 1 Characteristics of patients with PAH or CTEPH and healthy controls

From: Oxidative stress and nitric oxide signaling related biomarkers in patients with pulmonary hypertension: a case control study

Variables

PAH group (n = 12)

PAH-Control (n = 12)

Pvalue

CTEPH group (n = 23)

CTEPH-Control (n = 23)

Pvalue

Male, n (%)

2 (16.7)

2 (16.7)

1.000

12 (52.2)

11 (47.8)

0.768

Age, years

44.6 ± 13.1

44.8 ± 13.2

0.963

55.0 ± 11.6

55.7 ± 11.5

0.839

BMI, kg/m 2

25.66 ± 4.27

25.12 ± 3.73

0.894

25.75 ± 3.23

24.53 ± 3.01

0.748

Hypertension, n (%)

2 (16.7)

-

-

5 (21.7)

-

-

Diabetes Mellitus, n (%)

0 (0)

-

-

1 (4.3)

-

-

6MWD, m

253.50 (148.50, 368.25)

-

-

275.00 (150.00, 419.00)

-

-

NT-proBNP, pg/ml

1130.0 (373.9, 2312.0)

-

-

1723.0 (609.0, 3136.0)

-

-

mPAP, mmHg

50 (37, 55)

-

-

52 (49, 55)

-

-

PVRI, dyn · sec · m 2 /cm 5

1398.0 (1149.0, 2647.5)

-

-

2231.5 (1595.75, 2611.5)

-

-

CO, L/min

3.95 ± 1.21

-

-

3.45 ± 1.19

-

-

CI, L/min/m 2

2.27 ± 0.67

-

-

1.82 ± 0.52

-

-

  1. Data are presented as mean ± SD or median (interquartile range). PAH = pulmonary arterial hypertension; CTEPH = chronic thromboembolic pulmonary hypertension; BMI = body mass index; WHO = World Health Organization; 6MWD = 6-minute walk distance; NT-proBNP = N-terminal pro brain natriuretic peptide; mPAP = mean pulmonary arterial pressure; PVRI = pulmonary vascular resistance index; CO = cardiac output; CI = cardiac index.